Newsletters

  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
All
  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
IncentivesR&D Insight

Global views: UN Dialogue, WHO @ ECCMID, JPIAMR/JAMRAI (Christine Ardal video)

Dear All, Three global conversations to put on your listen-to-this list! One is this coming week, one is during ECCMID, …

Read More >
JobsY2021

WHO seeks experts for critical antibiotics advisory group

Dear All, WHO have opened a call for experts to be part of an Advisory Group on their Critically Important …

Read More >
R&D InsightY2021

WHO 2020 clinical/preclinical pipeline review; Chat with WHO’s Peter Beyer

Dear All, WHO have today updated their 2019 clinical/preclinical pipeline review by releasing their 2020 analyses of both the clinical …

Read More >
R&D InsightY2021

FDA-NIAID-CDC: Developing drugs for gonorrhea, 23 Apr 21 workshop

Dear All, FDA, NIAID and CDC have announced a public workshop on development considerations of antimicrobial drugs for the treatment …

Read More >
R&D InsightWonkish

Developing antibiotics for children: There are no easy answers

Aside: If you’ve enjoyed the prior discussions of movies to inspire antibiotic R&D and very apropos given the theme of today’s …

Read More >
R&D InsightY2021

Vaccines to turn back the tide of antimicrobial resistance

Dear All, As part of their Immunization Agenda 2030: A Global Strategy to Leave No One Behind, WHO have now …

Read More >
IncentivesR&D Insight

Stewardship & Access Guide from CARB-X, Wellcome, and partners: Analysis, video chat

Dear All, Novel antibacterial agents, vaccines, and diagnostics will do little if they are not widely available and used responsibly. …

Read More >
R&D InsightY2021

Amended Indian PPL slide / SUPERBUGS Act / Novo REPAIR Global Call

Dear All, Three bits of news you can use… First, when I wrote yesterday about the new Indian Priority Pathogen …

Read More >
R&D InsightY2021

Where’s the innovation? / Indian Priority Pathogen List / DTR video explainer

Dear All, Three things briefly this evening: First, the observation about the limited degree of innovation across products in Phases …

Read More >
IncentivesY2021

Pew infographic: Antibiotic R&D needs economic incentives

Dear All, I hope you have been enjoying the excellent new pipeline analysis from Pew Trusts (10 Mar 2021 newsletter) …

Read More >
R&D Insight

Updated global antibacterial pipeline review from Pew Trusts

Dear All, Pew Charitable Trusts have released an excellent update to their long-running series of pipeline reviews. Here are the …

Read More >
IncentivesR&D Insight

AMR Action Fund ($1b for P2-3): Video chat with new CEO! New committed funds!

Dear All, I’ve written before about the AMR Action Fund (9 Jul 2020 newsletter): In brief, it is ~$1b pledged by …

Read More >
IncentivesY2021

UK Antibiotic Subscription Pilot: Updates from a webinar

Dear All (and with thanks to Kevin Outterson for co-authoring), We’ve written and talked before from various perspectives about the …

Read More >
IncentivesMedia & Graphics

Brilliant 5-minute video explainer of the AMR problem!

 Dear All, Andrew Jack of the Financial Times (FT) has produced a superb 5-minute video explainer of the AMR challenge! …

Read More >
JobsY2021

Job with global impact: Director, CIDRAP Antimicrobial Stewardship Program

Dear All, Launched in 2016, the Antimicrobial Stewardship Program (ASP) at the Center for Infectious Disease Research and Policy (CIDRAP) …

Read More >
JobsY2021

Fabulous full-time AMR-focused leadership role at WHO! Apply now!

Dear All, Just now posted is an excellent opportunity to be a full-time Team Lead at WHO in the AMR …

Read More >
R&D InsightY2021

New YouTube videos! Cost of R&D, Antibiotic value, and Lessons from COVID

Dear All, For those of you who enjoy listening to learn, here are some updates to recent newsletters that you …

Read More >
R&D Insight

JPIAMR call: 25m Euro for interventions to reduce/prevent AMR

Dear All, JPIAMR is today launching an international call entitled “One Health interventions to prevent or reduce the development and …

Read More >
IncentivesR&D Insight

All-in cost of a new antibiotic from discovery to 10 years on market

Dear All (and with thanks to Kevin Krause for co-authoring this newsletter), The elements that contribute to the all-in cost …

Read More >
R&D Insight

FDA offers 2 fellowships and 3 RFPs! Endpoints, breakpoints, PROs & more!

Dear All, Our colleagues at FDA are planning some serious AMR-related research during 2021-22 with the following fellowships and RFPs. …

Read More >
Scroll to Top